Goulon M, Schortgen G, Tancrède C, Nouailhat F, Babinet P, Raphaël J C
Nouv Presse Med. 1975 Jan 4;4(1):13-6.
Enterobacteria multiresistant to usual antibiotics, often remain sensitive to nalidixic acid, sometimes as a result of synergy with polymixins. Use of the intravenous route makes it possible to obtain more than adequate serum levels. Pharmacological study has indicated appropriate doses in terms of renal function. Intravenous nalidixic acid has been used in the treatment of 31 cases of Gram negative septicaemia, with success in 22. These results are all the more significant given that the patients were all seriously ill, cultures having grown multiresistant organisms and that nalidixic acid was used only after other antibiotics had failed.
对常用抗生素多耐药的肠道杆菌,通常对萘啶酸仍敏感,有时是与多粘菌素协同作用的结果。采用静脉途径给药可使血清药物水平超过足够的浓度。药理研究已表明根据肾功能确定合适的剂量。静脉注射萘啶酸已用于治疗31例革兰阴性菌败血症,22例取得成功。鉴于所有患者病情均严重,培养出多耐药菌,且仅在其他抗生素治疗失败后才使用萘啶酸,这些结果就显得更有意义。